Middle East Pharmaceutical (4016)

Saudi Arabia
Currency in SAR
133.80
0.00(0.00%)
Delayed Data
4016 Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
133.20134.80
52 wk Range
90.20197.60
Key Statistics
Edit
Bid/Ask
133.00 / 134.20
Prev. Close
133.8
Open
134
Day's Range
133.2-134.8
52 wk Range
90.2-197.6
Volume
-
Average Volume (3m)
54.41K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4016 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
123.40
Downside
-7.77%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Middle East Pharmaceutical Company Profile

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central nervous, digestive, and musculoskeletal system medicines; urinary and reproductive system drugs; disinfectants; and various therapeutic medicines and preparations, including sexual system drugs, diabetes, cardiovascular drugs, anti-infective drugs, anti-parasitic drugs, pain relievers, antiseptics, and women’s and men’s health drugs in the form of creams, rolls, ointments, syrups, masks, tonics, lotions, capsules, gels, hand sanitizers, mouthwashes, soaps, solutions, sprays, scrubs, topical solutions, and tablets. The company also provides contract manufacturing services. In addition, it specializes in cosmetic, health products and nutritional supplements. The company also exports its products. Middle East Pharmaceutical Industries Company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006. Middle East Pharmaceutical Industries Company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.

Employees
543

Compare 4016 to Peers and Sector

Metrics to compare
4016
Peers
Sector
Relationship
P/E Ratio
33.3x11.7x−0.7x
PEG Ratio
0.350.240.00
Price/Book
8.2x1.9x2.6x
Price / LTM Sales
6.9x2.2x3.1x
Upside (Analyst Target)
−7.8%12.3%50.4%
Fair Value Upside
Unlock10.1%8.4%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 123.40
(-7.77% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.02
Dividend Yield
0.56%
Industry Median 0.86%
Annualised payout
0.7500
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 27, 2024
EPS / Forecast
-- / --
Revenue / Forecast
81.00M / 77.30M
EPS Revisions
Last 90 days

FAQ

What Is the Middle East Pharmaceutical (4016) Stock Price Today?

The Middle East Pharmaceutical stock price today is 133.80

What Stock Exchange Does Middle East Pharmaceutical Trade On?

Middle East Pharmaceutical is listed and trades on the Saudi Arabia stock exchange.

What Is the Stock Symbol for Middle East Pharmaceutical?

The stock symbol for Middle East Pharmaceutical is "4016."

Does Middle East Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Middle East Pharmaceutical dividend yield is 0.56%.

What Is the Middle East Pharmaceutical Market Cap?

As of today, Middle East Pharmaceutical market cap is 2.68B.

What is Middle East Pharmaceutical Earnings Per Share?

The Middle East Pharmaceutical EPS is 4.02.

What Is the Next Middle East Pharmaceutical Earnings Date?

Middle East Pharmaceutical will release its next earnings report on 30 Mar 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.